Foluso Agboola discusses the Institute for Clinical and Economic Review's newest analysis, which has found that most new ...

Although it’s commonly recommended to test for albuminuria in people with diabetes or high blood pressure, testing is often ...

A new digital health tool increased rates of lung cancer screening, according to research published Oct. 20 in JAMA. Investigators from Wake Forest University School of Medicine, ...

The oral microbiome is home to more than 700 species of bacteria, and the average person hosts approximately 250 species at a time, according to the study. Each person’s oral microbiome is unique and ...

These gaps stem from systemic barriers, including limited access to early detection, follow-up delays and inequities in ...

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring Pharmaceuticals news ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

Based on data including more than 788 million patient visits from more than 15,000 ophthalmologists, thousands of eyes were ...

Researchers of the National Eye Institute found that the supplement—now known as the AREDS formula, containing vitamins C and ...

Patients with Type 1 diabetes are often excluded from diabetes and weight loss trials. Forty years ago, the vast majority of patients with Type 1 diabetes didn’t need help with the problem of being ...

Bandyopadhyay and colleagues found that new T1D registrations were most likely to come from people under the age of 40, ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...